it is mostly found in the population restricted with dietary intake of B12-containing animal-derived foods
Cui S, Peng Q, Ma Q, Xu X, Zhang W, Jiang X, Tan S, Yang W, Han Y, Oyang L, et al
Retatrutide is an unapproved investigational triple agonist (GLP-1, GIP, glucagon receptors) not licensed by the MHRA, EMA, or FDA for routine clinical use
It can also be useful for treating burns, cuts, damaged skin
Healthcare providers can save valuable time that would otherwise be spent on manual calculations or consultations with pharmacists
The insights derived from this analysis will form the basis for structuring comprehensive guidelines tailored to the Mediterranean region's unique vulnerabilities